首页>
外国专利>
PHARMACEUTICAL TECHNOLOGY OF PHARMACEUTICAL COMPOSITION IN NOVEL/SEQUENTIAL DRUG DELIVERY SYSTEM CONTAINING NITRIC OXIDE DONOR
PHARMACEUTICAL TECHNOLOGY OF PHARMACEUTICAL COMPOSITION IN NOVEL/SEQUENTIAL DRUG DELIVERY SYSTEM CONTAINING NITRIC OXIDE DONOR
展开▼
机译:含一氧化氮供体的新型/序贯药物输送系统中药物成分的制药技术
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to pharmaceutical technology of pharmaceutical composition in Novel/Sequential Drug Delivery System containing Nitric Oxide Donors, more particularly, selective Endothelial Nitric Oxide Synthase Enhancers and in synergistic combination with Nitic Oxide Scavengers, Lipid Lowering Agents, as nanonized particles, from amongst, HMG Co-A Reductase Inhibitors, Ezetimibe and Fibrates and additionally other pharmaceutical substances that prevent/treat Atherosclerosis and provide round-the-clock cardio-protection. Following are the specific objectives of the present invention: a) Provide optimum benefits of Nitric Oxide and make it devoid of its adverse effects, through our unique technology and thus make it relatively safe for long-term usage. b) Provide synergistic combination of Lipid Lowering Agents with Nitric Oxide to achieve the dual objectives of a) Vasodilatation and b) Improve Dyslipidemia. c) Improve Quality of Life in patients with Ischemic Heart Disease.
展开▼